Dumalagan, Mary Joy .
HRN: 26-71-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2025
CEFUROXIME 1.5GM (VIAL)
04/12/2025
04/12/2025
IV
1500mg
Every 8 Hours
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes